Related News
Home 禄 Business 禄 Manufacturing
Merck-Simcere JV starts business in Pudong
By Ye Zhen |
September 13, 2012, Thursday
|
Online Edition
Online Edition
SMSD, a joint venture between US pharmaceutical giant Merck and Nanjing-based Simcere Pharmaceutical Group, went into operation yesterday after more than one year's preparation.
Merck, the world's second-largest drug maker, holds a 51 percent stake in the joint venture, which is located in Shanghai's Pudong New Area. SMSD currently has about 400 employees and the number is expected to double by the end of this year.
SMSD will initially sell medicines for cardiovascular and metabolic diseases with a focus on low-income groups in China. The medicines are produced in existing factories owned by the two parent companies before a new manufacturing facility is built in Nanjing, Jiangsu Province.
Merck, the world's second-largest drug maker, holds a 51 percent stake in the joint venture, which is located in Shanghai's Pudong New Area. SMSD currently has about 400 employees and the number is expected to double by the end of this year.
SMSD will initially sell medicines for cardiovascular and metabolic diseases with a focus on low-income groups in China. The medicines are produced in existing factories owned by the two parent companies before a new manufacturing facility is built in Nanjing, Jiangsu Province.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
